Residual daytime sleepiness (RES) in CPAP-treated obstructive sleep apnea (OSA) patients in the European Sleep Apnea Database (ESADA)
C. Barbera (Palermo, Italy), F. Cibella (Palermo, Italy), F. Fanfulla (Pavia, Italy), J. Pepin (Grenoble, France), W. Mc Nicholas (Dublin, Ireland), S. Schiza (Heraklion, Greece), T. Saaresranta (Turku, Finland), J. Hedner (Gothenburg, Sweden), L. Grote (Gothenburg, Sweden), J. Verbraecken (Antwerp, Belgium), M. Bonsignore On Behalf Of The Esada Study Group (Palermo, Italy)
Source: Virtual Congress 2021 – From phenotyping to different diagnostic tools for sleep breathing disorders
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Barbera (Palermo, Italy), F. Cibella (Palermo, Italy), F. Fanfulla (Pavia, Italy), J. Pepin (Grenoble, France), W. Mc Nicholas (Dublin, Ireland), S. Schiza (Heraklion, Greece), T. Saaresranta (Turku, Finland), J. Hedner (Gothenburg, Sweden), L. Grote (Gothenburg, Sweden), J. Verbraecken (Antwerp, Belgium), M. Bonsignore On Behalf Of The Esada Study Group (Palermo, Italy). Residual daytime sleepiness (RES) in CPAP-treated obstructive sleep apnea (OSA) patients in the European Sleep Apnea Database (ESADA). 2494
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: